The 2026 chemistry Nobel showed how one-handed molecules can emerge. It did not settle how life began. Here is what is proved, what is open, and why it matters for drugs.
When the 2026 Nobel Prize in Chemistry went to Henri Kagan and Kenso Soai, headlines quickly announced that the mystery of life’s handedness had been solved. The truth is more interesting, and more precise. The prize rewards a genuine answer to one question while leaving another, older one open.
What has been proved
The question Kagan and Soai answered is chemical: can a system of molecules, starting with almost no preference for left or right, end up overwhelmingly one-handed without outside help? For most of the twentieth century this was a theory. Kagan’s non-linear effect showed that a small imbalance in a catalyst can be magnified in a product. Soai’s reaction showed a molecule copying its own handedness, so that a trace excess grows to near purity in a few rounds.
The Nobel Committee’s conclusion was careful: thanks to these discoveries, we now know how homochirality can emerge. The key word is can. The laureates demonstrated a mechanism that works, under real laboratory conditions, which is far more than a hypothesis.
What has not
The older question is historical: how did life on Earth, more than three and a half billion years ago, come to use left-handed amino acids and right-handed sugars?
Here the committee’s own scientific background is unusually frank. It stresses that the mathematical model the laureates validated is not an answer to the origin of biological homochirality. A news report in Chemistry World went further, noting that exactly what happened when life’s homochirality first arose is unlikely ever to be known.
There is a practical reason for caution. The Soai reaction relies on an organozinc reagent that reacts violently with water and is used in carefully dried organic solvents. Nothing like it existed in the oceans, pools or hydrothermal vents where life is thought to have started. The reaction proves that self-amplification of handedness is chemically possible. It does not show that this particular chemistry took place on the early Earth.
So where did the first small imbalance come from, and what amplified it? Researchers are exploring several ideas. Circularly polarised light, produced in some star-forming regions, slightly favours destroying one mirror form over the other. Chiral mineral surfaces, such as those of quartz crystals, could select one form. Crystallisation can, in some systems, drive a mixture towards a single form. Even the weak nuclear force, which is known to distinguish left from right, produces a minute energy difference between mirror-image molecules. Some meteorites carry small excesses of one form of certain amino acids, hinting that a bias may have arrived from space. It is also possible that selection happened later, among early genetic molecules or peptides, rather than in simple chemistry.
None of these ideas has been ruled in. What Kagan and Soai contributed is the demonstration that, once any small bias exists, chemistry has a way to multiply it.
Why medicines care
The second reason this prize matters has little to do with the origin of life and much to do with the pharmacy shelf. Because the body is built of one-handed molecules, it often treats the two mirror forms of a drug differently. Peter Somfai of the Nobel Committee explained it in simple terms: the left-handed version of a drug can have one effect and the right-handed version another, so chemists need methods for preparing them selectively.
Many modern medicines are therefore sold as a single form. Several familiar drugs were reintroduced as pure single-enantiomer versions of older mixtures, a strategy known as a chiral switch: escitalopram from citalopram, esomeprazole from omeprazole, levocetirizine from cetirizine. Regulators in many countries expect drug makers to justify whether a chiral drug is developed as a mixture or a single form and to control its purity.
A familiar cautionary tale needs care. Thalidomide is often cited as a case where one form healed and the other harmed. In fact, thalidomide converts between its two forms inside the body, so a pure single-form version would not have prevented the tragedy.
The main industrial routes to single-form drugs are asymmetric catalysis, honoured with Nobel Prizes in 2001 and 2021, along with enzymes and the separation of mixtures. Kagan’s non-linear effect plays a quieter but valuable role: it helps chemists understand how their catalysts behave, which is essential in designing reactions for production. The committee itself noted that the laureates’ discoveries have been crucial for chemists designing reactions to make medicines.
The analytical side
Every single-form drug also has to be measured. Laboratories must show not only that the right molecule is present but that its mirror image is absent or below a set limit. Polarimetry, the descendant of Biot’s and Pasteur’s measurements, is still used, but modern quality control relies more on chiral chromatography, in which columns packed with a chiral material separate the two forms so each can be quantified. Circular dichroism spectroscopy and specialised NMR methods complete the toolkit. For a country such as India, which supplies a large share of the world’s generic medicines, this kind of chiral analysis is routine and essential work.
Kagan and Soai have explained how a mirror-image world can tip to one side. Why our own world tipped the way it did is still waiting for its answer.
– Pavan Katady
